Request Deal Involvement

Veracyte completed the acquisition of HalioDx from BPI France for $318m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Shearman & Sterling

legal advisors

Shearman & Sterling

ATCG Partners

pr advisors

ATCG Partners

Latham & Watkins

legal advisors

Latham & Watkins

Joele Frank

pr advisors

Joele Frank

Goldman Sachs

financial advisors

Goldman Sachs

Fenwick & West

legal advisors

Fenwick & West

Jones Day

legal advisors

Jones Day

or

Principals

HALIODX

target

HALIODX

VERACYTE

bidder

VERACYTE

BPIFRANCE INVESTISSEMENT

vendor

BPIFRANCE INVESTISSEMENT

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Veracyte completed the acquisition of HalioDx from BPI France for $318m.